AI-generated summary
The authors systematically reviewed PubMed for controlled trials of photobiomodulation therapy for xerostomia or salivary hypofunction caused by cancer treatment. Five controlled trials were included, mostly in head and neck cancer patients receiving radiotherapy, with conflicting results and one positive study in hematopoietic stem cell transplantation. The authors conclude it is too early to confidently determine efficacy.
- Studies included
- 5
- Who or what was studied
- Patients with xerostomia or salivary hypofunction related to cancer therapy, mainly head and neck cancer patients treated with radiotherapy or radiochemotherapy, and one study of patients with dry mouth after hematopoietic stem cell transplantation
- Limits stated in the abstract
- The authors state that results conflict across the included trials and that evidence is too limited to confidently determine efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.